Edition:
United States

Ascendis Pharma A/S (ASND.OQ)

ASND.OQ on NASDAQ Stock Exchange Global Select Market

59.41USD
3:59pm EST
Change (% chg)

$1.40 (+2.41%)
Prev Close
$58.01
Open
$58.00
Day's High
$60.14
Day's Low
$58.00
Volume
32,728
Avg. Vol
32,327
52-wk High
$76.98
52-wk Low
$35.02

Chart for

About

Ascendis Pharma A/S is a clinical-stage biopharmaceutical company. The Company is engaged in applying its TransCon technology to develop sustained release prodrug therapies with several product candidates in clinical and preclinical development. The Company is developing its product candidate, TransCon human growth hormone... (more)

Overall

Beta: --
Market Cap(Mil.): $1,304.09
Shares Outstanding(Mil.): 36.37
Dividend: --
Yield (%): --

Financials

  ASND.OQ Industry Sector
P/E (TTM): -- 83.95 33.59
EPS (TTM): -3.50 -- --
ROI: -83.31 -0.80 15.05
ROE: -83.31 -0.14 16.62

Earnings vs. Estimates